Trice launches AI-ready, EHR-interoperable reporting layer for fetal medicine
Trice Imaging has launched a reporting tool that pulls imaging, reporting and longitudinal patient data into a single connected workflow, pitched as the digital groundwork for AI-enabled fetal assessment.
Trice Workspace Reporting is built specifically for obstetrics and maternal-fetal medicine, and sits inside the company’s Tricefy image management platform.
It combines customisable reporting, dynamic pregnancy dating and longitudinal patient history with an AI-ready, EHR-interoperable infrastructure.
The company says the tool is designed to accelerate standardised and synchronised report turnaround, support timely clinical decisions and improve operational efficiency for fetal medicine services.
Mark A. Samii, chief revenue officer at Trice Imaging, said the tool was built for teams under pressure.
“Maternal fetal medicine teams are managing increasingly complex pregnancies while being asked to do more with limited time and resources,” he said.
“Trice Workspace Reporting is designed to remove unnecessary friction from reporting by creating a structured digital foundation that supports today’s need for connected clinical workflows. It also provides a digital foundation as practices prepare for tomorrow and the evolution of AI-enabled fetal assessment, anomaly detection and outcome prediction technologies.”
Despite declining birth rates worldwide, the complexity of pregnancy is increasing.
Advanced maternal age, IVF-assisted pregnancies, rising obesity rates and a higher prevalence of hypertension and diabetes mean more cases require specialist monitoring, advanced imaging and multidisciplinary care, while clinical teams are stretched and facing increasing administrative demands.
A global medical image management company, Trice has spent more than 17 years working on cloud-based storage, retrieval, display, organisation and exchange of ultrasound medical images and associated information across health environments.
Its platform is vendor-neutral and now extends to dynamic clinical reporting, AI-driven workflow optimisation, data analytics and secure patient engagement.
The company aims to cover the women’s health continuum, from IVF and reproductive health through maternal-fetal medicine and OB/GYN to lifelong women’s health, serving independent practices and large hospital ecosystems alike.
It holds regulatory and data protection clearances in 40 countries, and has offices in Miami and Stockholm plus a growing network of global distributors.
